Aladdin Healthcare Technologies SE Logo

Aladdin Healthcare Technologies SE

ISIN: DE000A12ULL2 | Ticker: NMI

About Aladdin Healthcare Technologies SE

Company Description

We are a multi-disciplinary team of scientists, biologists, clinicians, AI engineers and innovators.

Led by globally recognised scientists in the field of age-related disease with more than 1000 scientific publications and an AI team with more than 30 global AI awards.

Based on our proprietary award-winning AI solutions, Aladdin has developed 3 core platforms: Drug Discovery, Biomedical Knowledge Graphs and Disease Diagnosis.

These platforms will enable superior acceleration of the drug discovery process and deliver more accurate and cost-effective age-related disease diagnosis.

Year founded

2014

Served area

Worldwide

Headcount

3

Headquarters

Unter den Linden 10, 10117 Berlin – Germany

Insider Trades

Date Trading entity / Person Association Trade type Volume Average price
02.02.22 Menpes-Smith, Mr Wade Board Other 211,425.00 € 02.02.22
21.09.21 Continental Aktiengesellschaft Close relation Sell 243,288.00 € 21.09.21
20.09.21 Smith, Wade Board Other 211,425.00 € 20.09.21

Shareholder information

Shares outstanding

11,458,238

IPO

May 22, 2020

Stock exchange(s)

Berlin Stock Exchange, Düsseldorf Stock Exchange, Frankfurt Stock Exchange, Munich Stock Exchange

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.